Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pioglitazone × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3 Other hematologic neoplasm 2 Myeloid 2 Gastrointestinal 2 Tumor-Agnostic 1 Sarcoma 1 Head & Neck 1 Dermatologic 1 CNS 1

Conditions

Liposarcoma, Myxoid 1 Liposarcoma 1

Interventions

Radiotherapy 126 Temozolomide 101 Doxorubicin 98 Cyclophosphamide 98 Filgrastim 71 Ifosfamide 61 Imatinib Mesylate 60 Etoposide 57 Vincristine 47 Bevacizumab 47 Irinotecan 40 Gemcitabine 40 Peripheral Blood Stem Cell Transplantation 37 Methotrexate 34 Radiation 32 Carboplatin 30 Cisplatin 29 Busulfan 29 pazopanib 27 fludarabine phosphate 27 Trabectedin 27 Melphalan 26 Sirolimus 24 Sunitinib 22 Docetaxel 22 sargramostim 21 Magnetic Resonance Spectroscopy 21 Granulocyte Colony-Stimulating Factor 21 Carmustine 21 Sorafenib 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04794127 2026-02-18

TRABEPIO

Mario Negri Institute for Pharmacological Research

Phase 2 Completed

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡